Week 2 Flashcards
How do we analyze hyperglycemia in the lab? What are the time points at which we measure blood glucose levels and what is the relevance of each?
- Fasting
- 10-15 minutes after eating
- 2-3 hrs after eating
Fasting
- importance
- when is it taken?
- results
- gives you patient’s baseline glucose level.
- after 8-10 hrs of fasting
- Should be between 80-100mg/dL (5.5 mmol/L)
- If you are above or below this level, glucose metabolism is impaired for some reason
10-15 minutes after eating (post prandial)
- why this time
- measure of
- normal
- this is how long it takes the glucose to reach the blood -> will immediately be followed by the first phase of insulin release which is stored in secretory vessicles of pancreatic beta cells
- first phase insulin response
- Blood glucose goes up to 200 mg/dL
2-3 hrs after eating
- what does it measure
- normal
- how well blood glucose comes back down in an attempt to reach homeostasis
- Actually measuring the second and third phase of insulin release
- Blood glucose should be brought back down to 140 mg/dL
What symptoms would the patient present with if this was a case of type I diabetes?
- sxs in both DMI and DMII
- sxs only in DMI
- sxs in UA
- labs
- How would his symptoms differ for diabetes type II?
- polyuria, polydipsia, and blurred vision (overlap in both type I and type II diabetes because they are associated with hyperglycemia)
- You may see a history of weight loss, Insulin levels would be low (C-peptide)
- You would also see ketones in the urine analysis and ketoacidosis in the blood analysis (drop in pH)
- Free fatty acids would be elevated -> body is in a catabolic state since glucose utilization is impaired due to low insulin (beta cells are decreased).
- History of increased body weight, Tingling in the hands and feet, Increased appetite, Decreased muscle mass, Won’t see DKA in type II unless there is some kind of acute infection or stressor that really throws off the patient’s homeostasis which is pretty rare.
How to measure C-peptide
measure C peptide rather than measuring insulin directly because c peptide has a longer half-life
Type I Diabetes causes
- genetic
- drugs/chemicals
- medical causes
- There are 3 genetic causes: 1. MHC class II and HLA-DRs (type II), 2. VNTR (variable number tandem repeats) of a specific region, 3. VNTR of a specific length
- Chemotherapeutic drugs, High doses of steroid administration
- cystic fibrosis and pancreatic CA
MHC class II and HLA-DRs (type II)
- presentation
- down stream
- antigens
- external antigens and cause and autoimmune attack against pancreatic beta cells
- So, mutations in HLA- II mutations leads to structurally mutated MHCs (specifically mutated MHC class IIs). Mutated MHCs have structural modifications which allow them to present internal antigens rather than external antigens and activate T cells against self… this is what initiates the auto-immune attack against self pancreatic beta cells since they heavily produce these internal antigens
- insulin, tyrosine phosphatase (which is associated with insulin receptor activity), or GAD.
VNTR (variable number tandem repeats) of a specific region
upstream to the promoter region of the insulin gene itself
VNTR of a specific length
- 20-60 nucleotide base pair repeats upstream the promoter are generally found in individuals with type 1
- VNTRs must be found in both maternal and paternal (homozygous) insulin genes
Cystic Fibrosis
- Hypersecretion by the pancreas can clog/obstruct the exocrine pancreas which can cause pancreatitis and destruction of beta cells, decreasing insulin production.
- Really severe case of necrotizing pancreatitis which knocks out the vast majority of the pancreatic function in a single hit. But it would have to be very severe… severe enough to knock out 80-90% of the pancreas.
- This is rare, so chronic causes are more likely. Almost always, it is a chronic process with acute on chronic exacerbations of pancreatitis.
normal mechanism of insulin secretion
• Eat a meal, high levels of glucose in blood, gets to pancreatic beta cells by GLUT2 transporters (insulin independent at this point), gets locked by phosphorylation (turns to G6P), glucose kinase enzyme causes oxidative metabolism (glycolysis, TCA, ETC) and creates high amount of ATP production, so ATP:ADP ratio goes up, this is sensed by ATP sensitive K channels in membrane, they now close, locks potassium inside beta cells, leads to depolarization and opening of voltage gated Ca channels, Ca influxes in, Ca helps the insulin and C peptides (stored in equimolar amounts in secretory granules) released out into blood by exocytosis
If person has mutated glucokinase gene, makes glucokinase with much higher Km, what happens?
- what does higher Km mean?
- function of glucokinase
- name of this dx
- type of mutation
- when does this present
• Higher Km is lower affinity for substrate of glucokinase
• Phosphorylates and holds glucose in only when there’s high levels of glucose in beta cells and also in blood –> Once G6P goes to oxidative metabolism it drives the process of insulin release –> So insulin release would only happen in response to very very high blood glucose levels
• This is called GCK-MODY (Glucokinase Related Maturity Onset Diabetes of the Young)
○ Autosomal dominant mutation
- Patient presents with diabetes in a much earlier age (below 25)
Mutant ATP sensitive K channel, what happens?
- name? when does it start?
- specific mutation
• Decreased insulin release
• Another genetic form of diabetes: Neonatal diabetes –> Have diabetes right from birth
- Can be treated but not cured
- Potassium channel made up of 8 different transmembrane domains, 4 of them made from 1 gene and the others from a second gene: KCNJ11 (makes 4 domains); ABCC8 (other 4 genes)
- Neonatal diabetes can be associated with mutations in the insulin gene itself
Sulfonylureas alter insulin secretion
- how does it work
- when is it used
• Binds to a domain of the K channel and closes it
- Used for treatment of Type II diabetes
Type of receptor for insulin
-pathway
- RTK
- Insulin binds, dimerization, autophosphorylation of the beta components of the receptor, phosphorylates downstream to get activation of those pathways and leads to upregulation of GLUT 4 receptors
Target organ insulin binds to
- Liver
- Muscles
- Adipose
- Decreased gluconeogenesis, Increased glycogen synthesis, Increase lipogenesis
- Increased glucose uptake, Increased glycogen synthesis, Increased protein synthesis
- Increased glucose uptake, Increased lipogenesis, Decreased lipolysis
Big picture thing that insulin does?
Increasing anabolic process to increase glucose uptake and utilization
Difference between insulin sensitivity vs resistance?
- sensitivity
- Resistance
- At level of liver, what happens?
- At level of skeletal muscle
- Adipose tissue
- Receptors are responding to insulin, With high sensitivity need lower amount of insulin for uptake
- Receptors aren’t responding to insulin
- Glucose uptake decreases, Glycogen synthesis decreases, Blood glucose levels elevated
- Decreased glucose uptake, decreased glycogen synthesis
- Activation of hormone sensitive lipase (HSL), excess triglyceride breakdown, excess free fatty acid circulation
How does DMII develop
- other dx they will most likely have
- doesn’t usually occur in isolation
- Unless there’s a specific gene variant like in MODY, we’re going to see that there’s a wide array of different predisposing factors
- unusual for standard case of Type II diabetes to be seen without components of metabolic syndrome
- metabolic syndrome, HTN, dyslipidemia, and eventually down the line would develop atherosclerotic vascular disease
Central adipose vs peripheral
- difference in function
- difference in location and importance
- how does this cause inflammation
- Central adipose is more lipolytic, it will increase free fatty acid production which will lead to abnormal signaling inside the cells.
- Central is near the liver -> closer to portal circulation -> fat will enter the portal circulation -> increase in free fatty acids in vessel which are broken down and will lead to accumulation of DAG -> allows for increase in toxic metabolites, and increase in gluconeogenesis and glucose levels
- Adipocytes release TNF-alpha and proinflammatory cytokines.
adipokines
- what do they do?
- effect on glucose?
- when are they released with obesity?
- what happens to glucose bc of increased fat?
- what does this do to insulin
- Leptin, adiponectin
- Satiety signals; Normally decrease blood glucose levels
- Adiponectin are reduced in obesity and that contributes to insulin resistance. Leptin levels may also go down and you become leptin resistant. What do leptin and adiponectin do?
- greater central adipose tissue -> less production of adipokines -> no regulation of blood glucose at level of fat -> cause increase in blood glucose.
- get insulin resistance bc of always having too much glucose
What happens to glucose, fat, and AA metabolism in Type I DM
- insulin levels
- glucagon
- glucose utilization
- how do they have energy?
- liver
- fat
- Insulin levels will be low
- Glucagon levels will be high
- Glucose utilization in cells is low. PFK 2 activates PFK 1 (glycolysis) by insulin, so low insulin means this can’t happen–> low glucose utilization-> low ATP production from glucose -> cell compensates by shifting to beta oxidation (levels high in cells)
- Protein is catabolizing to support gluconeogenesis bc glucose crisis in cell and cell needs to make more glucose –> Alanine, asparate converts to pyruvate and goes to gluconeogenesis; Ketogenic amino acids form, degrade into Acetyl CoA
- Liver has a lot of acetyl CoA, with excess it’s going to convert them into ketones and release out into blood -> Ketoacidosis in blood
- High glucagon affects fat metabolism by lipolysis
Activates HSL, high amount of release of fat from periphery into blood, can contribute to high lipid levels in blood
Insulin and gluconeogenesis
- Normally insulin de-activates PEP carboxykinase –> With insulin resistance, it can’t be dephosphorylated and cannot be deactivated; it remains active
Insulin and lypolysis
- results in?
- Normally, insulin suppresses HSL and induces more storage of fats in periphery but with DMII HSL can’t be turned down
- More free FA in blood, more triglycerides in blood, liver takes up lots of fat bc there’s lots of nonesterified free FA in blood –> liver compacts excess fats in form of VLDL–> sends out in blood, so VLDL and LDL levels are all elevated so make person prone to CVD –> So much fat in liver which sits there and leads to non alcoholic fatty liver disease
How to Dx DM
- acute
- chronic
• C-peptide levels: C-peptide is a marker of your endogenous insulin production, So T1DM will have Low C peptide and T2DM will initially have high, then later low C peptide when your beta population goes down
- Diagnosed with HbA1C: Non-enzymatic glycation of hemoglobin in the RBCs
Stays longer & bc RBCs live for 120 days, high hba1c is indicative of poor management of diabetes
marker for how quickly DMI will progress
- Really low C-peptide level = really low insulin level to start with, means patient will probably have a more severe progression of T1DM
How to manage T1DM
- how many carbs per serving
- saturated fat and Na
- transfat
- how can you get away with having more carbs?
- reduce overall load of glucose -> comes from carb counting
- ~15
- 5% or less
- 0
- if most of those carbs are from fiber
What is a one carb serving
- bread
- oatmeal
- pasta/rice
- starchy veggies
- dairy
- fruit
- 1 slice of bread
- 1/2 cup oats
- 1/2 bagel
- 1/3 cup cooked pasta or rice
- 1/2 cup starchy veggies
- 1 cup skim milk
- 1 small piece, 1/2 cup cubed fruit, 1/3-1/2 cup juice
Healthy Plate for Diabetes
- g of carbs
- rice
- non-starchy veggies
- protein
- yogurt or skim milk
- 40-45
- 1/4 the plate–1/2 cup
- 1/2 plate
- 1/4 plate
- 1 cup
Rapid acting insulin
- when to give
- Aspart, lispro, glulisine
- Right before meal
Regular insulin
- when to give
- why is this important?
- other name
- the peak is a little delayed so you have to do that 20-30 min before the meal
- So again with the carb counting, knowing how many carbs you’re about to eat so you can give yourself the right dose ahead of time
- Sometimes called insulin R
NPH insulin
- other name
- time duration
- dosage
- insulin N
- middle
- twice a day – 1 in morning and other at dinner
Detemir
- how long?
- closer to full day but not all the way
Glargine
- duration?
- 24 hours
- Eventually clears
How to dose insulin for T1DM
- dose for T2?
- overdose?
- Rapid acting before meals + long acting to prevent basal hyperglycemia
- Usually just long acting, dont add short acting until it gets bad
- will cause hypoglycemia which can lead to death
Potential complications of diabetes mellitus
- general
- autoimmune
- psch
- metabolic
- vascular
- poor height/weight gain
- delayed development
- autoimmune thyroidits and celiac disease
- depression and eating disorders
- DKA
- nephropathy, HTN, neuropathy, retinopathy
Patho underlying the potential complications
- AGES & RAGES
- ROS & inflammation
What is a biguanides
- exmple
- group of oral type 2 diabetes drugs that work by preventing the production of glucose in the liver , improving the body’s sensitivity towards insulin and reducing the amount of sugar absorbed by the intestines
- metformin
Sulfonylureas
- examples
- increase insulin secretion by pancreatic beta cells by binding to the potassium membrane channel we were looking at earlier
- slimepiride, glipizide, and glyburide